EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis

Béguelin, Wendy, Teater, Matt, Gearhart, Micah D., Calvo Fernández, María Teresa, Goldstein, Rebecca L., Cárdenas, Mariano G., Hatzi, Katerina, Rosen, Monica +11 more·2016·Cancer Cell

DOI 10.1016/j.ccell.2016.07.006

Cited by (258)

Items 101–200 of 258

OFCD syndrome and extraembryonic defects are revealed by conditional mutation of the Polycomb-group repressive complex 1.1 (PRC1.1) gene BCOR
Michelle Y. Hamline, Connie M. Corcoran, Joseph A. Wamstad, Isabelle Milétich, Jifan Feng, Jamie L. Lohr, Myriam Hemberger, Paul Thomas Sharpe, Micah D. Gearhart, Vivian J. Bardwell · 2020 · Developmental Biology
Accelerated plasma-cell differentiation in Bach2-deficient mouse B cells is caused by altered IRF4 functions
Kyoko Ochiai, Hiroki Shima, Toru Tamahara, Nao Sugie, Ryo Funayama, Keiko Nakayama, Tomohiro Kurosaki, Kazuhiko Igarashi · 2024 · The EMBO Journal
BCL ‐6 promotes the methylation of miR ‐34a by recruiting EZH2 and upregulating CTRP9 to protect ischemic myocardial injury
Jiunn‐Miin Lin, Chih‐Hsiang Hsu, Robert Jeenchen Chen, Shao‐Hsuan Kao, You‐Cian Lin · 2021 · BioFactors
Structural heterogeneity of the mammalian polycomb repressor complex in immune regulation
Seok Jin Kang, Taehoon Chun · 2020 · Experimental & Molecular Medicine
Disrupting the Code: Epigenetic Dysregulation of Lymphocyte Function during Infectious Disease and Lymphoma Development
Andrea Di Pietro, Kim L. Good‐Jacobson · 2018 · The Journal of Immunology
Progression of AITL-like tumors in mice is driven by Tfh signature proteins and T-B cross talk
Mariko Witalis, Jinsam Chang, Ming‐Chao Zhong, Yasser C Bouklouch, Vincent Panneton, Joanna Li, Thorsten Buch, Seok Jin Kim, Won Seog Kim, Young Hyeh Ko et al. · 2020 · Blood Advances
Polycomb group proteins in cancer: multifaceted functions and strategies for modulation
S P Wang, Sandra Carolina Ordonez‐Rubiano, Alisha Dhiman, Guanming Jiao, Brayden P. Strohmier, Casey J. Krusemark, Emily C. Dykhuizen · 2021 · NAR Cancer
H3K27me3 Demethylase UTX Restrains Plasma Cell Formation
Anna K. Kania, Madeline J. Price, Lou-Ella George-Alexander, Dillon G. Patterson, Sakeenah L. Hicks, Christopher D. Scharer, Jeremy M. Boss · 2022 · The Journal of Immunology
Drug discovery and therapeutic delivery for the treatment of B and T cell tumors
Regan E. Stephenson, Ankur K. Singh · 2017 · Advanced Drug Delivery Reviews
Structure and Role of BCOR PUFD in Noncanonical PRC1 Assembly and Disease
Sarah J. Wong, Olga Senkovich, Jason A. Artigas, Micah D. Gearhart, Udayar Ilangovan, David W. Graham, Kelsey N. Abel, Tianrong Yu, Andrew P. Hinck, Vivian J. Bardwell et al. · 2020 · Biochemistry
Epigenetic Mechanisms of Therapy Resistance in Diffuse Large B Cell Lymphoma (DLBCL)
Yusuke Isshiki, Ari M. Melnick · 2021 · Current Cancer Drug Targets
Tumor-associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B cell lymphoma
Katsuyoshi Takata, Lauren C. Chong, Daisuke Ennishi, Tomohiro Aoki, Michael Yu Li, Avinash Thakur, Shannon Healy, Elena Viganò, Tao Dao, Daniel Kwon et al. · 2022 · Journal of Clinical Investigation
Epigenetic Mechanisms in Leukemias and Lymphomas
Cihangir Duy, Wendy Béguelin, Ari M. Melnick · 2020 · Cold Spring Harbor Perspectives in Medicine
BCL6 and the Notch pathway: a signaling axis leading to a novel druggable biotarget in triple negative breast cancer
Francesca De Santis, Sandra Lorena Romero-Cordoba, Lorenzo Castagnoli, Tatiana Volpari, Simona Faraci, Giovanni Fucà, Elda Tagliabue, Filippo de Braud, Serenella Maria Pupa, Massimo Di Nicola · 2022 · Cellular Oncology
Loss of cohesin regulator PDS5A reveals repressive role of Polycomb loops
Daniel Bsteh, H. F. Moussa, Georg Michlits, R. Yelagandula, Jing-Kui Wang, U. Elling, O. Bell · 2021 · bioRxiv
Emerging role of noncanonical polycomb repressive complexes in normal and malignant hematopoiesis
Yusuke Isshiki, Atsushi Iwama · 2018 · Experimental Hematology
Pathogenic Impacts of Dysregulated Polycomb Repressive Complex Function in Hematological Malignancies
Satoshi Kaito, Atsushi Iwama · 2020 · International Journal of Molecular Sciences
Non-Hodgkin Lymphomas: Malignancies Arising from Mature B Cells
Jennifer R. Shingleton, Jie Wang, Carolyn Baloh, Tushar Dave, Nicholas S. Davis, Lanie E. Happ, Othmane Jadi, Rachel Kositsky, Xiang Li, Cassandra Love et al. · 2020 · Cold Spring Harbor Perspectives in Medicine
CBX8 promotes tumorigenesis and confers radioresistance in esophageal squamous cell carcinoma cells through targeting APAF1
Yixuan Zhang, Hui Chen, Hongcheng Zhu, Xinchen Sun · 2019 · Gene
Evolving insights into the genomic complexity and immune landscape of diffuse large B-cell lymphoma: opportunities for novel biomarkers
Siba El Hussein, Kenna R Mills Shaw, Francisco Vega · 2020 · Modern Pathology
Comprehensive analysis of the prognosis for chromobox family in gastric cancer
Lin Kang, Jinfeng Zhu, Cegui Hu, Fanqin Bu, Chen Huan Luo, Xiaojian Zhu, Zhengming Zhu · 2020 · Journal of Gastrointestinal Oncology
EZH2 Inhibitors: Take It EZy, It Is All About Context
Vamsidhar Velcheti, Kwok‐Kin Wong, Yogen Saunthararajah · 2019 · Cancer Discovery
EZH2: Its regulation and roles in immune disturbance of SLE
Yiying Yang, Ke Liu, Meidong Liu, Huali Zhang, Muyao Guo · 2022 · Frontiers in Pharmacology
In situ neoplasia in lymph node pathology
Naoki Oishi, Santiago Montes‐Moreno, Andrew L. Feldman · 2017 · Seminars in Diagnostic Pathology
Molecular heterogeneity in diffuse large B-cell lymphoma and its implications in clinical diagnosis and treatment
Lingchuan Guo, Pei Lin, Hui Xiong, Shichun Tu, Gang Chen · 2018 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
The direct and indirect regulation of follicular T helper cell differentiation in inflammation and cancer
Yejin Cao, Lin Dong, Ying He, Xuelian Hu, Yueru Hou, Yingjie Dong, Qiuli Yang, Yujing Bi, Guangwei Liu · 2021 · Journal of Cellular Physiology
Autophagy Modulators in Cancer: Focus on Cancer Treatment
Hye Jin Nam · 2021 · Life
Follicular Lymphoma Microenvironment: An Intricate Network Ready for Therapeutic Intervention
Cèlia Dobaño‐López, Ferran Araujo‐Ayala, Neus Serrat, Juan García Valero, Patricia Pérez‐Galán · 2021 · Cancers
Targeting DOT1L and EZH2 synergizes in breaking the germinal center identity of diffuse large B-cell lymphoma
Camiel Göbel, Rachele Niccolai, Marnix H. P. de Groot, Jayashree Jayachandran, Joleen J.H. Traets, Daan J. Kloosterman, Sebastian Gregoricchio, Ben Morris, Maaike Kreft, Ji‐Ying Song et al. · 2025 · Blood
Epigenetics of the antibody and autoantibody response
Justin B. Moroney, Daniel Phillip Chupp, Zhenming Xu, Hong Zan, Paolo Casali · 2020 · Current Opinion in Immunology
BCL6 Inhibitor-Mediated Downregulation of Phosphorylated SAMHD1 and T Cell Activation Are Associated with Decreased HIV Infection and Reactivation
Yanhui Cai, Mohamed Abdel‐Mohsen, Costin Tomescu, Fengtian Xue, Guoxin Wu, Bonnie J. Howell, Yong Ai, Jie Sun, Livio Azzoni, Carole Le Coz et al. · 2018 · Journal of Virology
EZH2 inhibition dampens autoantibody production in lupus by restoring B cell immune tolerance
Yiying Yang, Muyuan Li, Yaxi Zhu, Ke Liu, Meidong Liu, Yanjuan Liu, Ganqian Zhu, Hui Luo, Xiaoxia Zuo, Huali Zhang et al. · 2023 · International Immunopharmacology
Synergistic antitumor effect of combined EZH2 and DOT1L inhibition in B-cell lymphoma
Van T.M. Nguyen, Hiroe Namba, Hayley Porter, Daria Shlyueva, Ernesto López, Alan A. Melcher, Wendy Béguelin, Ari M. Melnick, Kristian Helin · 2025 · Blood
Murine models of germinal center derived-lymphomas
Parham Ramezani-Rad, Robert C. Rickert · 2017 · Current Opinion in Immunology
FBXL10 contributes to the development of diffuse large B-cell lymphoma by epigenetically enhancing ERK1/2 signaling pathway
Xiujuan Zhao, Xing Wang, Qian Li, Wanbiao Chen, Na Zhang, Yu Kong, Junqiang Lv, Lei Cao, Dan Lin, Xi Wang et al. · 2018 · Cell Death and Disease
The oncoprotein BCL6 enables solid tumor cells to evade genotoxic stress
Yanan Liu, Juanjuan Feng, Kun Yuan, Zhengzhen Wu, Longmiao Hu, Yue Lu, Kun Li, Jiawei Guo, Jing Chen, Chengbin Ma et al. · 2022 · eLife
Know when to fold ‘em: Polycomb complexes in oncogenic 3D genome regulation
Emma J. Doyle, Lluís Morey, Eric Conway · 2022 · Frontiers in Cell and Developmental Biology
Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer
Xiang Lin, Jidong Chen, Chen-Yu Wang, Zhen Cai, Rui Zhan, Yang Chen, La-Ying Zhang, Lianyun Li, Yong Xiao, Mingkai Chen et al. · 2023 · Genome biology
BCOR-coupled H2A monoubiquitination represses a subset of androgen receptor target genes regulating prostate cancer proliferation
Joanna K. Lempiäinen, A.B.M. Kaiser Manjur, Marjo Malinen, Kirsi Ketola, Einari A. Niskanen, Jorma J. Palvimo · 2020 · Oncogene
Transcription Factor Co-expression Networks of Adipose RNA-Seq Data Reveal Regulatory Mechanisms of Obesity
Rúta Skinkyté-Juskiené, Lisette J. A. Kogelman, Haja N. Kadarmideen · 2018 · Current Genomics
Advances in understanding the formation and fate of B-cell memory in response to immunization or infection
Liam C. Kealy, Kim L. Good‐Jacobson · 2021 · Oxford Open Immunology
Novel insights into the dynamic function of PRC2 in innate immunity
Rosalie W.M. Kempkes, Rab K. Prinjha, Menno P.J. de Winther, Annette E. Neele · 2024 · Trends in Immunology
Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancer
Hussein Ghamlouch, Eileen Mary Boyle, Patrick Blaney, Yubao Wang, Jinyoung Choi, Louis S. Williams, Michael Bauer, Daniel Auclair, Benedetto Bruno, Brian A. Walker et al. · 2021 · Journal of Experimental & Clinical Cancer Research
Inhibition of H3K27me3 Demethylases Promotes Plasmablast Formation
Anna K. Kania, Muyao Guo, Christopher D. Scharer, Jeremy M. Boss · 2021 · ImmunoHorizons
CBX8 promotes lung adenocarcinoma growth and metastasis through transcriptional repression of CDKN2C and SCEL
Hao Chen, Yijie Su, Lihong Yang, Lishan Xi, Xuanyuan Li, Bei Lan, Min Liu, Chenghao Xuan · 2023 · Journal of Cellular Physiology
Human B Lymphomas Reveal Their Secrets Through Genetic Mouse Models
Noushin Mossadegh‐Keller, Gabriel Brisou, Alicia Beyou, Bertrand Nadel, Sandrine Roulland · 2021 · Frontiers in Immunology
Mouse Models of Germinal Center Derived B-Cell Lymphomas
Stefanie N. Meyer, Sanjay Koul, Laura Pasqualucci · 2021 · Frontiers in Immunology
BCL6 BTB‐specific inhibitor reversely represses T‐cell activation, Tfh cells differentiation, and germinal center reaction in vivo
Yanhui Cai, Adi Narayana Reddy Poli, Surya Kumari Vadrevu, Kwasi Gyampoh, Colin Hart, Brian N. Ross, Matt Fair, Fengtian Xue, Joseph M. Salvino, Luis J. Montaner · 2021 · European Journal of Immunology
Biology as vulnerability in follicular lymphoma: genetics, epigenetics, and immunogenetics
Ferran Araujo‐Ayala, Wendy Béguelin · 2025 · Blood
The germinal center in the pathogenesis of B cell lymphomas
Laura Pasqualucci · 2023 · Hematological Oncology
BCL6 BTB‐specific inhibition via FX1 treatment reduces Tfh cells and reverses lymphoid follicle hyperplasia in Indian rhesus macaque (Macaca mulatta)
Yanhui Cai, Meagan Watkins, Fengtian Xue, Yong Ai, Huiming Cheng, Cecily C. Midkiff, Xiaolei Wang, Xavier A. Alvarez, Adi Narayana Reddy Poli, Joseph M. Salvino et al. · 2019 · Journal of Medical Primatology
Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma
Man Chun John Ma, Saber Tadros, Alyssa Bouska, Tayla Heavican, Haopeng Yang, Qing Deng, Dalia Moore, Ariz Akhter, Keenan Hartert, Neeraj Jain et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
A Promising Future for Precision Epigenetic Therapy for Follicular and Diffuse Large B-Cell Lymphoma?
Clement Chung · 2022 · Blood and Lymphatic Cancer Targets and Therapy
Molecular Pathogenesis of Follicular Lymphoma: From Genetics to Clinical Practice
Cristina López, Pablo Mozas, Armando López‐Guillermo, Sı́lvia Beà · 2022 · Hemato
Rituximab-Based Therapy in Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients: Individualized Risk-Adapted Therapy Approach Using Molecular Subtypes
Lei Fan, Lindong Li, Yiqun Zhou, Jianyong Li · 2017 · Journal of Hematology
Dysregulated translational factors and epigenetic regulations orchestrate in B cells contributing to autoimmune diseases
Ming Yang, Ping Yi, Jiao Jiang, Ming Zhao, Haijing Wu, Qianjin Lu · 2021 · International Reviews of Immunology
Histone bivalency in CNS development
Kärt Mätlik, Eve‐Ellen Govek, Mary E. Hatten · 2025 · Genes & Development
Epigenetic regulatory protein chromobox family regulates multiple signalling pathways and mechanisms in cancer
Weiyu Su, Weiwen Wang, Guanghui Zhang, Lianhe Yang · 2025 · Clinical Epigenetics
Harnessing lymphoma epigenetics to improve therapies (article not eligible for CME credit)
Haopeng Yang, Michael R. Green · 2020 · Hematology
Harnessing lymphoma epigenetics to improve therapies
Haopeng Yang, Michael R. Green · 2020 · Blood
miR-155 aberrant expression impairs tumor rejection because of its targeting of ICOSL and multiple pathways implicated in the antitumor response
Esmerina Tili, Jean‐Jacques Michaille, Carlo Maria Croce · 2025 · Pharmacological Reviews
One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies
Antonia Kalushkova, Patrick Nylund, Alba Atienza Párraga, Andreas Lennartsson, Helena Jernberg‐Wiklund · 2021 · Epigenomes
Alterations in transcriptional networks in cancer: the role of noncoding somatic driver mutations
Ashley S. Doane, Olivier Elemento · 2022 · Current Opinion in Genetics & Development
Potential Epigenetic Regulation in the Germinal Center Reaction of Lymphoid Tissues in HIV/SIV Infection
Xiaolei Wang, Huanbin Xu · 2018 · Frontiers in Immunology
Epigenetic dynamics in normal and malignant B cells: die a hero or live to become a villain
Jared M. Andrews, Jacqueline E. Payton · 2018 · Current Opinion in Immunology
B cells turn on, tune in with LSD1
Kim L. Good‐Jacobson · 2018 · Nature Immunology
Mouse Models in the Study of Mature B-Cell Malignancies
Laura Pasqualucci, Ulf Klein · 2020 · Cold Spring Harbor Perspectives in Medicine
EZH2 coordinates memory B-cell programming and recall responses
Keenan J Wiggins, Mark E Williams, Sakeenah L. Hicks, Herbey Oswaldo Padilla-Quirarte, Jobaida Akther, Troy D. Randall, Jeremy M. Boss, Christopher D. Scharer · 2025 · The Journal of Immunology
Fibroblasts‐specific p16INK4a exacerbates inflammageing‐mediated post‐infarction ventricular remodelling through interacting with STAT3 to regulate NLRP3 transcription
Xin Gu, Yingqiang Du, Jinge Zhang, Jiyu Li, Haiyun Chen, Yujie Lin, Yue Wang, Chunli Zhang, Shiyu Lin, Nannan Hao et al. · 2025 · Clinical and Translational Medicine
Epigenetic Regulation of B Cell Memory Formation: A Poised Model for B Cell Epigenetic Reprograming
Carlos Valverde-Hernandez · 2025 · Journal of Immunology Research
Genetics and epigenetics of leukemia and lymphoma: from knowledge to applications, meeting report of the Josep Carreras Leukaemia Research Institute
Maribel Parra, Maria João Baptista, Eulàlia Genescà, Pere Llinàs‐Arias, Manel Esteller · 2020 · Hematological Oncology
Hyperforin modulates MAPK/CCL11 signaling to reduce the inflammatory response of nasal mucosal epithelial cells caused by allergic rhinitis by targeting BCL6
Chen Xu, Wen Su · 2023 · Experimental and Therapeutic Medicine
EZH2 Expression in Follicular Lymphoma Is Variable and Independent from the Progression of Disease Within 24 Months of First Treatment
Anna Szumera‐Ciećkiewicz, Jan Poleszczuk, Ewa Paszkiewicz‐Kozik, Grzegorz Rymkiewicz, Kamil Sokół, Anita Borysiuk, Martyna Kotarska, Daria Owczarek, Monika Kawecka, Beata Pytlak et al. · 2020 · Anticancer Research
The Role of Epigenetic Mechanisms in B Cell Lymphoma Pathogenesis
Leandro Venturutti, Ari M. Melnick · 2020 · Annual Review of Cancer Biology
Polycomb Assemblies Multitask to Regulate Transcription
Miguel Vidal · 2019 · Epigenomes
Bivalent chromatin protects reversibly repressed genes from irreversible silencing
Dhirendra Kumar, Raja Jothi · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Re-evaluating the role of nucleosomal bivalency in early development
Rohan N. Shah, Adrian T. Grzybowski, Jimmy Elias, Zhonglei Chen, Takamitsu Hattori, Carolin C. Lechner, Peter W. Lewis, Shohei Koide, Beat Fierz, Alexander J. Ruthenburg · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Resveratrol as a BCL6 natural inhibitor suppresses germinal center derived Non-Hodgkin lymphoma cells growth
Yajing Xing, Chunbin Tan, Zhoujiang Liu, Yanqi Liu, Simei Liu, Guixue Wang, Yadong Zhong · 2025 · Journal of Natural Medicines
Mutant EZH2 alters the epigenetic network and increases epigenetic heterogeneity in B cell lymphoma
Ofir Griess, Noa Furth, Nofar Harpaz, Nicoletta Di Bernardo, Tomer‐Meir Salame, Bareket Dassa, Ioannis Karagiannidis, Yusuke Isshiki, Menachem Gross, Ari M. Melnick et al. · 2025 · PLoS Biology
Mouse models of diffuse large B cell lymphoma
Areya Tabatabai, Aastha Arora, Svenja Höfmann, Maximilian Jauch, Bastian von Tresckow, Julia Hansen, Ruth Flümann, Ron Daniel Jachimowicz, Sebastian Klein, Hans Christian Reinhardt et al. · 2023 · Frontiers in Immunology
Rôle de EZH2 comme biomarqueur dans le traitement personnalisé du myélome multiple
Laurie Herviou, Giacomo Cavalli, Jérôme Moreaux · 2018 · Bulletin du Cancer
Pharmacological targeting of CBX7 alters the epigenetic landscape and induces differentiation of leukemic cells
Anne P. de Groot, Chelsea R. Wilson, Ellen Weersing, Jacobine S Pouw, Albertina Dethmers-Ausema, Huong Nguyen, E. C. Chen, Alok Shaurya, Linda Smit, Fraser A. Hof et al. · 2024 · Blood Neoplasia
New murine models of aggressive lymphoma
Ruth Flümann, Pascal Nieper, Hans Christian Reinhardt, Gero Knittel · 2019 · Leukemia & lymphoma/Leukemia and lymphoma
T follicular helper cells transiently unlock a plasticity state in germinal centre B cells during the humoral immune response
Laurianne Scourzic, Franco Izzo, Matt R. Teater, Alexander Polyzos, Lucretia Cucereavii, Christopher R. Chin, Antonin Papin, Hugo Borges Pinto, Coraline Mlynarczyk, Ioanna Tsialta et al. · 2025 · Nature Cell Biology
B-cell intrinsic regulation of antibody mediated immunity by histone H2A deubiquitinase BAP1
Yue Liang, HanChen Wang, Noé Seija, Yun Hsiao Lin, Lin Tze Tung, Javier Marcelo Di Noia, David Langlais, Anastasia Nijnik · 2024 · Frontiers in Immunology
Correlation between B-cell lymphoma 6 with the balance of T helper-1/2 and severity of allergic rhinitis
Jiali Wu, Shumei Chen, Xiaoyan Li · 2023 · Allergologia et Immunopathologia
An Orally Available Small Molecule BCL6 Inhibitor Effectively Suppresses Diffuse Large B Cell Lymphoma Cells Growth in Vitro and in Vivo
Yajing Xing, Weikai Guo, Min Wu, Jiuqing Xie, Dongxia Huang, Pan Hu, Miaoran Zhou, Lin Zhang, Qiansen Zhang, Peili Wang et al. · 2021 · Research Square
Derepressing of STAT3 and USP7 contributes to resistance of DLBCL to EZH2 inhibition
Chenyun He, Wenbin Zhou, Xiaoxia Jin, Haining Zhou · 2023 · Heliyon
Developmental stage and cellular context determine oncogenic and molecular outcomes of Ezh2Y641F mutation in hematopoiesis
Sarah M. Zimmerman, Samantha J. Procasky, Sofia R Smith, Jieyu Liu, Chad Torrice, George P. Souroullas · 2025 · Blood Neoplasia
Aberrant splicing of MBD1 reshapes the epigenome to drive convergent myeloerythroid defects in MDS
He Tian Chen, Pratik Joshi, Séverine Cathelin, Soheil Jahangiri, Saeer A Adeel, Joshua Xu, Emily Tsao, Yulin Mo, David Kealy, Adam Dowle et al. · 2026 · Blood
Overcoming CAR-T bottlenecks in high-risk DLBCL: a molecular subtyping enhancement strategy
Rubing Zheng, Xiaojian Zhu, Yi Xiao · 2025 · Cancer Cell International
How CBX proteins regulate normal and leukemic blood cells
Anne P. de Groot, Gerald de Haan · 2024 · FEBS Letters
A Small-Molecule BCL6 Inhibitor as an Anti-Proliferative Agent for Diffuse Large B-Cell Lymphoma
Yajing Xing, Weikai Guo, Min Wu, Jiuqing Xie, Dongxia Huang, Pan Hu, Miaoran Zhou, Lin Zhang, Yadong Zhong, Mingyao Liu et al. · 2024 · Molecular Cancer Therapeutics
In vivo CRISPR screening reveals cooperation of KMT2D and TP53 deficiencies in B-cell lymphomagenesis
Kentaro Yamaguchi, Junji Koya, Kota Mizuno, Yosuke Mizukami, Kota Yoshifuji, Yuki Saito, Mariko Tabata, Sumito Shingaki, Mitsuhiro Yuasa, Yuta Ito et al. · 2025 · Blood Advances
Genomic Drivers in Follicular Lymphoma
Saber Tadros, Michael R. Green · 2019 · Springer eBooks
Combinatorial Tethering: A Novel Mode to Recruit Non-canonical PRC1 for Normal and Malignant GC B Cell Development
Bernd B. Zeisig, Chi Wai Eric So · 2016 · Cancer Cell
Biological and clinical significance of epigenetic alterations in B-cell lymphomas
Daisuke Ennishi · 2022 · International Journal of Hematology
Generation of a Murine Model for c-MYC and BCL2 Co-expression B Cell Lymphomas
Zhenming Cai, Le Zhang, Min Cao, Yuliang Wang, Feng Wang, Weiqi Bian, Sulan Zhai, Xiaoming Wang · 2020 · Frontiers in Oncology
Loss of function mutations of BCOR in classical Hodgkin lymphoma
Maciej Giefing, Micah D. Gearhart, Markus Schneider, Birte Malaika Overbeck, Wolfram Klapper, Sylvia Hartmann, Adam Ustaszewski, Marc A. Weniger, Laura Wiehle, Martin‐Leo Hansmann et al. · 2021 · Leukemia & lymphoma/Leukemia and lymphoma
Genetic Mouse Models of Lymphomas
Gero Knittel, Hans Christian Reinhardt · 2024 · Methods in molecular biology